
Keywords: Circulating tumor cells (CTC); Breast cancer; Hormone receptor positive; Fulvestrant; Aromatase inhibitors; AI; aromatase inhibitor; BCL2; B-cell lymphoma 2; CCS; charcoal stripped calf serum; CTC; circulating tumor cells; EpCAM; epithelial cell adhesion